Patents by Inventor Gregory Paul Roth

Gregory Paul Roth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10637855
    Abstract: A server obtains a challenge from another computer system during a negotiation with a client according to a protocol. The server injects the challenge into a message of the protocol to the client. The client uses the challenge in an authentication request. The server submits the authentication request to the other computer system for verification. The other computer system verifies the authentication request using a key registered to the client. The server operations are further dependent at least in part on whether verification of the authentication request was successful.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: April 28, 2020
    Assignee: Amazon Technologies, Inc.
    Inventors: Andrew Paul Mikulski, Nicholas Alexander Allen, Gregory Branchek Roth
  • Patent number: 10542005
    Abstract: The launching of new software code, virtual machines, and other such instances can undergo one or more scans before being fully available in an electronic environment. One or more policies may apply to such a launch, which can cause the launch to first be performed under a first network configuration, wherein the instance may not be granted access to resources other than scanning infrastructure. After one or more scans are performed, the results can be compared against the policies and, if the results pass, the instance can be caused to operate in a second network configuration, whether launching a new instance in a production environment, altering the configuration of the network, or other such tasks. The policies can be set by a provider of the relevant resources, an administrator of one or more affected resources, an administrator of the instance, or another appropriate party.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: January 21, 2020
    Assignee: AMAZON TECHNOLOGIES, INC.
    Inventors: Gregory Branchek Roth, Andrew Paul Mikulski
  • Publication number: 20190199726
    Abstract: The launching of new software code, virtual machines, and other such instances can undergo one or more scans before being fully available in an electronic environment. One or more policies may apply to such a launch, which can cause the launch to first be performed under a first network configuration, wherein the instance may not be granted access to resources other than scanning infrastructure. After one or more scans are performed, the results can be compared against the policies and, if the results pass, the instance can be caused to operate in a second network configuration, whether launching a new instance in a production environment, altering the configuration of the network, or other such tasks. The policies can be set by a provider of the relevant resources, an administrator of one or more affected resources, an administrator of the instance, or another appropriate party.
    Type: Application
    Filed: February 28, 2019
    Publication date: June 27, 2019
    Inventors: Gregory Branchek Roth, Andrew Paul Mikulski
  • Publication number: 20120046329
    Abstract: Disclosed herein are compositions and methods relating to modulators of Nod-like Receptors NOD1 (NLRC1) and NOD2 (NLRC2) signaling. Further provided are methods of identifying modulators of Nod-like Receptors NOD1 and NOD2 activity. Further provided are compositions and methods for treating or preventing inflammation, including diseases associated with inflammation such as inflammatory bowel diseases (Crohn's disease, ulcerative colitis), pancreatitis, arthritis, asthma, psoriasis. Alzheimer's disease, cardiovascular disease (arteritis), diabetes, and sepsis.
    Type: Application
    Filed: August 10, 2011
    Publication date: February 23, 2012
    Inventors: Gregory Paul Roth, Ricardo Garcia Correa, Pasha Moeenuddin Khan, John Christian Reed
  • Patent number: 7550461
    Abstract: Disclosed are amide compounds of formula (I): wherein Ar1, Q, Y and R3-R6 of formula (I) are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: June 23, 2009
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Donghong Amy Gao, Daniel R. Goldberg, Abdelhakim Hammach, Ming-Hong Hao, Victor Marc Kamhi, Neil Moss, Kevin Chungeng Qian, Gregory Paul Roth, Christopher Ronald Sarko, Alan David Swinamer, Zhaoming Xiong
  • Patent number: 7138420
    Abstract: Disclosed are substituted benzimidazole compounds of formula (I): wherein R1, R2, R3, R4 and Xa are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: November 21, 2006
    Assignee: Boehringer Ingelheim Pharmaceuticals Inc.
    Inventors: Joerg Martin Bentzien, Brian Nicholas Cook, Charles Cywin, Roman Wolfgang Fleck, Ho Yin Lo, Peter Allen Nemoto, Steven S. Pullen, Gregory Paul Roth, Roger John Snow, Hidenori Takahashi, Ji Wang, Kevin J. Moriarty, Lei Qiao, Michael Winters
  • Patent number: 7115644
    Abstract: Disclosed are benzimidazolone compounds of formulas (I) & (II): wherein R1, R2, R3, R4, R5, X, L, m, n and t are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease.
    Type: Grant
    Filed: September 3, 2003
    Date of Patent: October 3, 2006
    Assignee: Boehringer Ingelheim Pharmaceuticals Inc.
    Inventors: Antonio Jose del Moral Barbosa, Jr., Daniel R. Goldberg, Abdelhakim Hammach, Pingrong Liu, Neil Moss, Mark Stephen Ralph, Gregory Paul Roth, Christopher Ronald Sarko, Fariba Soleymanzadeh, Andre White
  • Patent number: 6991766
    Abstract: Disclosed is an apparatus for automated synthesis containing a shaker deck with a plurality of reaction blocks containing a plurality of reaction wells, an arm containing an array of extending units capable of actuating physical steps along a plurality of axes of each reaction block, each reaction block being situated on a turntable, each turntable being further capable of rotating the reaction block along a central axis. Also disclosed are methods of preparing a peptide, oligonucleotide an small molecules using the apparatus.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: January 31, 2006
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Gregory Paul Roth, Roy Lewis Barr, Junefredo Fajardo Apon, Steven Russell Bush, Thomas James Baiga
  • Patent number: 6825219
    Abstract: Disclosed are substituted benzimidazole compounds of formula(I): wherein R1, R2, R3, R4 and Xa are defined herein. The compounds of the invention are useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: November 30, 2004
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Charles Cywin, Jinbo Lee, Steven S. Pullen, Gregory Paul Roth, Christopher Ronald Sarko, Roger John Snow, Noel Stewart Wilson
  • Publication number: 20040192748
    Abstract: Disclosed are benzimidazolone compounds of formulas (I) & (II): 1
    Type: Application
    Filed: September 3, 2003
    Publication date: September 30, 2004
    Applicant: Boehringer Ingelheim Parmaceuticals, Inc.
    Inventors: Antonio Jose del Moral Barbosa, Daniel R. Goldberg, Abdelhakim Hammach, Pingrong Liu, Neil Moss, Mark Stephen Ralph, Gregory Paul Roth, Christoper Ronald Sarko, Fariba Soleymanzadeh, Andre White
  • Publication number: 20030225053
    Abstract: Disclosed are amide compounds of formula(I): 1
    Type: Application
    Filed: April 10, 2003
    Publication date: December 4, 2003
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Donghong Amy Gao, Daniel R. Goldberg, Abdelhakim Hammach, Ming-Hong Hao, Victor Marc Kamhi, Neil Moss, Kevin Chungeng Qian, Gregory Paul Roth, Christopher Ronald Sarko, Alan David Swinamer, Zhaoming Xiong
  • Publication number: 20030144281
    Abstract: Disclosed are substituted benzimidazole compounds of formula(I): 1
    Type: Application
    Filed: November 5, 2002
    Publication date: July 31, 2003
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Charles Cywin, Jinbo Lee, Steven S. Pullen, Gregory Paul Roth, Christopher Ronald Sarko, Roger John Snow, Noel Stewart Wilson